Biocytogen (Beijing) Pharmaceutical Technology Co., Ltd. ("Biocytogen," SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful ...
Polydopamine-coated magnetic liposomes offer insight into the lectin–glycan interactions in motion. By observing minute ...
Under Sheriff Carmine Marceno’s leadership, the county’s homicide rates are at historic lows, major narcotics operations have ...
Gesture Technology Partners, LLC, Appeal No. 2025-1075 (Fed. Cir. Dec. 1, 2025) - In our Case of the Week, the Federal ...
The trillion-dollar club is ripe with technology giants, from Nvidia to Apple and Microsoft. That's because investors have ...
The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...
After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...
RLX Technology's potential FY26 dividend yield is estimated to be at the mid-single-digit percentage level. Find out why RLX ...
Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular ...
SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...
The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...
What's really holding America back in the biopharma race against China isn't just Beijing's subsidies or cheaper labor. It's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback